Omalizumab effect on eosinophilic otitis media and sinusitis: A case report

Hidetoshi Oshima, Toshimitsu Kobayashi, Tetsuaki Kawase

Research output: Contribution to journalArticlepeer-review


Omalizumab, a monoclonal antibody to human IgE, is used to treat severe asthma and is reportedly effective in other allergic diseases. We report a case of eosinophilic otitis media and sinusitis improved by omalizumab treatment. A 66-year-old woman with severe asthma, eosinophilic otitis media, and sinusitis had omalizumab started to treat asthma. Besides rapidly improving asthma symptoms, it ameliorated eosinophilic otitis media and sinusitis, confirming its hoped for effectiveness.

Original languageEnglish
Pages (from-to)319-323
Number of pages5
JournalPractica Oto-Rhino-Laryngologica
Issue number5
Publication statusPublished - 2011 May 1


  • Eosinophilic otitis media
  • Eosinophilic sinusitis
  • Omalizumab

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Omalizumab effect on eosinophilic otitis media and sinusitis: A case report'. Together they form a unique fingerprint.

Cite this